glp-1 neuroendocrine tumor Drugs and Cancer: What a New Study Suggests Survival Benefits of GLP-1 Receptor

Therefore, we can speculate that obesity and increased subcutaneous adipose tissue in both cases may be associated with increased drug half-life and prolonged toleration period

There is also the issue of treatment fatigue

We studied 36,674 women aged 18 to 50 with a diagnosis of PCOS who filled a new prescription for either a GLP-1 or metformin between January 2021 and November 2024

If you specifically want tirzepatide (the active ingredient in Mounjaro/Zepbound), narrow your search to Eden Health , Peter MD, Shed Rx, or Defy Medical, since many providers only offer compounded semaglutide

Its all about the science

Clinical Context Relevant to GLP-1 Treatment Discussions in 2026 GLP-1 receptor agonists like semaglutide represent a class of medications originally developed for type 2 diabetes management that have demonstrated meaningful effects on weight management in clinical research